The Procter & Gamble Company Website

The Procter & Gamble Company

NYSE-PG

Basic

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    $83.91B

  • Employees

    108,000

Margins

  • Gross

    51.76%

  • EBITDA

    28.65%

  • Operating

    25.17%

  • Pre-Tax

    21.57%

  • Net

    17.06%

  • FCF

    18.9%

Returns (5Yr Avg)

  • ROA

    11.28%

  • ROTA

    57.5%

  • ROE

    28.6%

  • ROCE

    22.08%

  • ROIC

    14.03%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $12.16B

  • Net Debt

    $24B

  • Debt/Equity

    0.69

  • EBIT/Interest

    22.51

Growth (CAGR)

  • Rev 3Yr

    2.84%

  • Rev 5Yr

    4.05%

  • Rev 10Yr

    0.59%

  • Dil EPS 3Yr

    1.95%

  • Dil EPS 5Yr

    29.7%

  • Dil EPS 10Yr

    4.7%

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    65.48%

  • DPS

    $3.89

  • DPS Growth 3Yr

    5.45%

  • DPS Growth 5Yr

    5.88%

  • DPS Growth 10Yr

    4.57%

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Jun '15

Jun '16

Jun '17

Jun '18

Jun '19

Jun '20

Jun '21

Jun '22

Jun '23

Jun '24

LTM

Jun '25 (E)

Jun '26 (E)

Jun '27 (E)

Metric
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
LTM

Operating Revenues

70,950

76,118

80,187

82,006

84,039

83,905

Total Revenues

70,950

76,118

80,187

82,006

84,039

83,905

Total Revenues % Chg.

4.8%

7.3%

5.3%

2.3%

2.5%

0.8%

Cost of Goods Sold, Total

35,250

37,108

42,157

42,600

40,600

40,479

Gross Profit

35,700

39,010

38,030

39,406

43,439

43,426

Selling General & Admin Expenses, Total

19,597

20,527

19,585

20,349

22,491

22,308

Other Operating Expenses, Total

19,597

20,527

19,585

20,349

22,491

22,308

Operating Income

16,103

18,483

18,445

19,057

20,948

21,118

Interest Expense, Total

-465

-502

-439

-756

-925

-938

Interest And Investment Income

155

45

51

307

473

480

Net Interest Expenses

-310

-457

-388

-449

-452

-458

Other Non Operating Income (Expenses)

54

-392

-57

83

271

330

EBT, Excl. Unusual Items

15,847

17,634

18,000

18,691

20,767

20,990

Restructuring Charges

—

—

—

—

—

—

—

—

-329

-658

-1,544

Impairment of Goodwill

—

—

—

—

—

—

—

—

—

—

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

—

—

Asset Writedown

—

—

—

—

—

—

—

—

-1,341

-1,341

Legal Settlements

—

—

—

—

—

—

—

—

—

—

Other Unusual Items

—

-13

-19

-5

-9

-7

-7

EBT, Incl. Unusual Items

15,834

17,615

17,995

18,353

18,761

18,098

Income Tax Expense

2,731

3,263

3,202

3,615

3,787

3,693

Earnings From Continuing Operations

13,103

14,352

14,793

14,738

14,974

14,405

Earnings Of Discontinued Operations

—

—

—

—

—

—

—

—

Minority Interest

-76

-46

-51

-85

-95

-88

Net Income

13,027

14,306

14,742

14,653

14,879

14,317

Preferred Dividend and Other Adjustments

263

271

281

282

284

286

Net Income to Common Incl Extra Items

12,764

14,035

14,461

14,371

14,595

14,031

Net Income to Common Excl. Extra Items

12,764

14,035

14,461

14,371

14,595

14,031

Total Shares Outstanding

2,479.7

2,429.7

2,393.9

2,362.1

2,357.1

2,355

Weighted Avg. Shares Outstanding

2,487.1

2,465.8

2,410.3

2,368.2

2,360.1

2,359.2

Weighted Avg. Shares Outstanding Dil

2,625.8

2,601

2,539.1

2,483.9

2,471.9

2,469.6

EPS

5.1

5.7

6

6.1

6.2

5.9

EPS Diluted

5

5.5

5.8

5.9

6

5.8

EBITDA

19,116

21,218

21,252

21,771

23,844

24,040

Effective Tax Rate

17.2%

18.5%

17.8%

19.7%

20.2%

20.4%